Rivara Silvia, Lorenzi Simone, Mor Marco, Plazzi Pier Vincenzo, Spadoni Gilberto, Bedini Annalida, Tarzia Giorgio
Dipartimento Farmaceutico, Università degli Studi di Parma, Italy.
J Med Chem. 2005 Jun 16;48(12):4049-60. doi: 10.1021/jm048956y.
Three-dimensional homology models of human MT(1) and MT(2) melatonin receptors were built with the aim to investigate the structure-activity relationships (SARs) of MT(2) selective antagonists. A common interaction pattern was proposed for a series of structurally different MT(2) selective antagonists, which were positioned within the binding site by docking and simulated annealing. The proposed antagonist binding mode to the MT(2) receptor is characterized by the accommodation of the out-of-plane substituents in a hydrophobic pocket, which resulted as being fundamental for the explanation of the antagonist behavior and the MT(2) receptor selectivity. Moreover, to assess the ability of the MT(2) receptor model to reproduce the SARs of MT(2) antagonists, three new derivatives of the MT(2) selective antagonist N-[1-(4-chloro-benzyl)-4-methoxy-1H-indol-2-ylmethyl]-propionamide (7) were synthesized and tested for their receptor affinity and intrinsic activity. These compounds were docked into the MT(2) receptor model and were submitted to molecular dynamics studies, providing results in qualitative agreement with the experimental data. These results confirm the importance of the out-of-plane group in receptor binding and selectivity and provide a partial validation of the proposed G protein-coupled receptor model.
构建了人MT(1)和MT(2)褪黑素受体的三维同源模型,旨在研究MT(2)选择性拮抗剂的构效关系(SARs)。针对一系列结构不同的MT(2)选择性拮抗剂提出了一种共同的相互作用模式,这些拮抗剂通过对接和模拟退火定位在结合位点内。所提出的拮抗剂与MT(2)受体的结合模式的特征在于平面外取代基容纳在疏水口袋中,这被证明是解释拮抗剂行为和MT(2)受体选择性的基础。此外,为了评估MT(2)受体模型重现MT(2)拮抗剂SARs的能力,合成了MT(2)选择性拮抗剂N-[1-(4-氯苄基)-4-甲氧基-1H-吲哚-2-基甲基]-丙酰胺(7)的三种新衍生物,并测试了它们的受体亲和力和内在活性。将这些化合物对接至MT(2)受体模型,并进行分子动力学研究,得到的结果与实验数据在定性上一致。这些结果证实了平面外基团在受体结合和选择性中的重要性,并为所提出的G蛋白偶联受体模型提供了部分验证。